Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2001-08-28
2009-02-17
Canella, Karen A (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S388100, C530S388800
Reexamination Certificate
active
07491801
ABSTRACT:
The present invention relates to novel antibodies, antibody fragments and antibody conjugates which display a high degree of selectivity for squamous cell carcinoma antigens including carcinomas of the lung, esophagus and cervix. The present invention relates to both in vivo and in vitro clinical screening methods for diagnosis or prognosis of carcinomas by means of detecting the expression of squamous cell carcinoma antigens in biological samples of the subject using the novel antibodies of the invention. The invention further provides for kits for carrying out the above described screening methods. Additionally, antibody conjugates may be used to efficiently deliver various agents which have anti-tumor effects to the tumor cell. The antibodies of the invention may also be administered to a patient in non-conjugated form to target ADCC to the tumor cell.
REFERENCES:
patent: 4376110 (1983-03-01), David et al.
patent: 4579827 (1986-04-01), Sakamoto et al.
patent: 4713352 (1987-12-01), Bander et al.
patent: 4737579 (1988-04-01), Hellstrom et al.
patent: 4753894 (1988-06-01), Frankel et al.
patent: 4916055 (1990-04-01), Yeoman et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5212085 (1993-05-01), Wands et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5595898 (1997-01-01), Robinson et al.
patent: 5665848 (1997-09-01), Barnard
patent: 5688657 (1997-11-01), Tsang et al.
patent: 0155172 (1985-09-01), None
patent: 0184906 (1986-06-01), None
patent: 0252769 (1988-01-01), None
patent: 0526888 (1993-02-01), None
patent: 92/22324 (1992-12-01), None
patent: 95/03828 (1995-02-01), None
patent: 01/05427 (2001-01-01), None
patent: 02/074251 (2002-09-01), None
Drexler et al (Leukemia and Lymphoma, 1993, 9:1-25).
Hsu (in Tissue Culture Methods and Applications, Kruse and Patterson, Eds, 1973, Academic Press, NY, see abstract, p. 764).
Embleton et al (Immunol Ser, 1984, 23:181-207).
Kaiser (Science, 2006, 313:1370).
Weiner (Seminars Oncology, vol. 26, No. 4, 1999, pp. 41-50).
Internal Medicine, 4th Edition, Editor-in-chief Jay Stein, (Elsevier Science, 1998 Chapters 71-72, pp. 699-715).
Kimmel et al (J. Neurosurg, 66:161-171, 1987).
White et al. (2001, Ann. Rev. Med., 2001, 52:125-145).
Christiansen et al (Mol Cancer Ther, 2004, 3:1493-1501).
Topp et al (Journal of Controlled Release, 1998, 53:15-23).
Gura (Science, 1997, 278:1041-1042).
Pancreas Cancer Web, hosted at URL: http://www.path.jhu.edu/pancreas/, Copyright © 2006 The Johns Hopkins University, Baltimore, Maryland, Last Modified: May 12, 2006.
Arlen, Myron et al. (2001) “The Identification And Development Of Specific Monclonal Antibodies To Squamous Cell Carcinoma.” Critical Reviews In Immunology. 21(1-3):205-214.
Arlen et al. (2001) Abstract #P74 entitled “Development of a therapeutic monoclonal antibody against high grade recurrent colon and pancreatic cancer.” Presented at the 54th Annual Cancer Symposium, Society of Surgical Oncology, Mar. 15-18, 2001. Washington D.C.
Lee et al. (1999) “Generation and characterization of a novel single-gene-encoded single-chain immunoglobulin molecule with antigen binding activity and effector functions.” Mol Immunol. 36(1):61-71.
Nadkarni, Jagdish S. et al. (1998) “Characterization Of A Murine Monoclonal Antibody Against Human Esophageal Squamous Cell Carcinoma-Associated Antigen.” Tumori. 84(5):578-582.
Nakao et al. (1997) “Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.” Am J Gastroenterol. 92(6): 1031-1034.
Simons et al. (1997) “Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.” Cancer Res. 57(8): 1537-46.
Yamada et al. (1996) “Aberrant Expression Of A Hemidesmosomal Protein, Bullous Pemphigold Antigen 2, In Human Squamous Cell Carcinoma.” Laboratory Investigation 75(4): 589-600.
Sung et al. (1995) “Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck.” Int J Cancer. 61(6): 864-872.
Bird et al. (1988) “Single-Chain Antigen-Binding Proteins.” Science 242: 423-426.
Arlen Myron
Tsang Kwong Y.
Canella Karen A
International Bioimmune Systems, Inc.
Nixon & Peabody LLP
Reddig Peter J
LandOfFree
Identification and development of specific monoclonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Identification and development of specific monoclonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification and development of specific monoclonal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4138150